Acteoside Counteracts Interleukin-1<i>β</i>-Induced Catabolic Processes through the Modulation of Mitogen-Activated Protein Kinases and the NF<i>κ</i>B Cellular Signaling Pathway

<div>Acteoside suppressed the expression of IL-1<i>β</i>-induced catabolic proinflammatory cytokines, chemokines, and growth factors in primary rat chondrocytes. Primary rat chondrocytes were treated with 50 <i>μ</i>M acteoside in the presence or absence of 10 ng/mL IL-1<i>β</i> for 24 h. Total proteins were extracted, and the cytokine array was performed according the manufacturer’s instructions.</div>

Oxidative Medicine and Cellular Longevity

fig6

Figure 6

Figure 6: Acteoside Counteracts Interleukin-1<i>β</i>-Induced Catabolic Processes through the Modulation of Mitogen-Activated Protein Kinases and the NF<i>κ</i>B Cellular Signaling Pathway 

Figure 6 | Acteoside Counteracts Interleukin-1β-Induced Catabolic Processes through the Modulation of Mitogen-Activated Protein Kinases and the NFκB Cellular Signaling Pathway 